Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Which Funds Beat Active Funds Index helps readers compare strategies and track records, highlighting criteria to identify consistent, low-cost winners.
23,766 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
U.S. airline stocks rise on easing fuel costs, led by American Airlines and United, as crude prices slip and margins ...
Geopolitical tensions around Iran are pushing oil volatility and, in turn, accelerating EV adoption. Analysts warn th...
A church elder in Raleigh reports a fellow congregant pushing whole life insurance to attendees, sparking a Ramsey Sh...
Hidden costs are rewriting the cost of homeownership. Property taxes and insurance are rising faster than many buyers...
A long-standing rule for taking money in retirement is evolving. This article explains why this retirement rule thumb...
A playful plea becomes a genuine acting gig, illustrating how smart side gigs can diversify income. Here’s what perso...
A new software-first speed boost from DeepSeek challenges Nvidia's layered hardware strategy. This deep dive explains...
BNB Chain rolls out BNB Agent Studio, a platform to deploy autonomous AI agents that can earn crypto and survive infr...
Discover how general mills (gis) 2026 could unfold, with a focus on brand strength, cost discipline, and capital allo...
Zillow accuses Midwest Real Estate Data and Compass of weaponizing MLS rules to curb its access to listings, with a h...
When a company's chief financial officer sells a sizable stake, investors want to know what it means. This deep dive ...